Skip to main content
OpenTrials
Completed

NCT Number: NCT04438265

Quadratus Lumborum Type 2 as Chronic Hip Pain Treatment

The main objective of the study is to assess whether the performance of type 2 quadratus lumborum block produces an improvement in the quality of life of the patient with osteoarthritis of the hip.

Completed

Looking for future studies?

Notify Me

Key information

Age range

18 year–85 year

Sex eligibility

All sexes

Study type

Observational

Primary location

María Teresa Fernandez

Valladolid, Castille and León, 47008, Spain

About this study

The quadratus lumborum block is an interfascial block of the posterior wall of the abdomen, initially described for the management of postoperative pain in abdominal surgery due to its suggested effect on the T7-11 roots. The analgesic efficacy of type 1 quadratus lumborum block (QL1) in hip surgery was subsequently published. Regarding chronic pain, QL2 has been successfully performed in posttherniorrhaphy pain or pancreatic cancer.

This quadratus lumborum type 2 or posterior, is performed in the patients with hip joint based on the innervation of the hip and taking the role of thoraco-lumbar fascia in the analgesia of these patients as a reference. The good results obtained in the first 5 patients have led us to evaluate whether this blockade can indeed be an analgesic alternative in patients with coxarthrosis.

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • Sign informed consent (Annex 2)
  • Age 18-85 years
  • Cartilage injury (coxarthrosis) hip
  • Illness <1 year of evolution
  • Patients with pain after treatment with physical therapy, exercises, NSAIDs.
  • EVN> 5

Exclusion criteria

  • Refusal of the patient
  • Allergy to the drugs used
  • Contraindication for performing the technique
  • Intraarticular treatment in the previous 3 months
  • Pregnancy

Treatment and study plan

Levobupivacaine

Drug

local anesthetic

Other names: chirocane

Ultrasound device

Device

scream

Primary outcomes

  1. relieve chronic hip pain

    Time frame: 3 months

    The main objective of the study is to assess whether the performance of type 2 lumbar .square block produces an improvement in the quality of life of the patient with osteoarthritis of the hip. The evaluation of the patient will consist of 2 stages. The first of these will consist of the evaluation consultation

    evaluation with verbal numeric scale (VNS: 0 no dolor-10 the worst pain imaginable ) if patients improve their quality of pain

Secondary outcomes

  1. rate of adverse effects of the block

    Time frame: 3 months

    find if there is complications (hematome, kidney punction...)

Other outcomes

  1. relieve chronic pain at 6 month

    Time frame: 6 months

    the main objective was to asses how long was the effect of the analgesia

Sponsors and collaborators

Lead sponsor

Hospital Medina del Campo

Other

Collaborators

  • Hospital Rio Hortega
  • Hospital Universitaio Getafe

Registry information

Important dates

Study start
2020
Primary completion
2022
Study completion
2024
First posted
Jun 18, 2020
Registry last updated
Oct 23, 2024

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.